CRISPR screens revealed that SGF29 is required to sustain the transcription of key AML oncogenes, and SGF29 loss markedly impairs leukaemic self-renewal across multiple AML subtypes [59]. This evidence concerns the gene SGF29 and acute myeloid leukemia.